tradingkey.logo

Nuwellis Inc

NUWE
3.750USD
-0.100-2.60%
終値 02/02, 16:00ET15分遅れの株価
5.12M時価総額
0.02直近12ヶ月PER

Nuwellis Inc

3.750
-0.100-2.60%

詳細情報 Nuwellis Inc 企業名

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Incの企業情報

企業コードNUWE
会社名Nuwellis Inc
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)
従業員数38
証券種類Ordinary Share
決算期末Feb 16
本社所在地12988 Valley View Rd
都市EDEN PRAIRIE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55344
電話番号19523454200
ウェブサイトhttps://www.nuwellis.com/
企業コードNUWE
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)

Nuwellis Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Fri, Jan 2
更新時刻: Fri, Jan 2
株主統計
種類
株主統計
株主統計
比率
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
他の
91.93%
株主統計
株主統計
比率
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
他の
91.93%
種類
株主統計
比率
Investment Advisor/Hedge Fund
5.41%
Investment Advisor
2.18%
Hedge Fund
0.40%
Research Firm
0.13%
Individual Investor
0.02%
他の
91.87%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
20
134.31K
8.11%
+91.72K
2025Q3
18
13.52K
2.03%
+10.09K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Sabby Management, LLC
35.89K
2.16%
+32.37K
+918.85%
Sep 30, 2025
DRW Securities, LLC
36.08K
2.18%
+36.08K
--
Sep 30, 2025
Bigger Capital Funds, LP
5.69K
0.34%
+5.69K
--
Jun 09, 2025
Citi Investment Research (US)
1.15K
0.13%
+1.15K
--
Sep 30, 2025
Tower Research Capital LLC
1.03K
0.06%
+898.00
+680.30%
Sep 30, 2025
UBS Financial Services, Inc.
2.86K
0.17%
+979.00
+52.10%
Sep 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
SBI Securities Co., Ltd.
63.00
0%
+2.00
+3.28%
Sep 30, 2025
The Vanguard Group, Inc.
31.00
0%
--
--
Nov 30, 2025
BofA Global Research (US)
5.00
0%
+4.00
+400.00%
Sep 30, 2025
詳細を見る

関連ETF

銘柄名
比率
データなし

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
日付
配当落ち日
種類
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
詳細を見る
KeyAI